Chainalysis says a $100 million gray-market peptide industry increasingly relies on Bitcoin and stablecoins as traditional payment channels close.
Crypto News
Some of the Chinese chemical manufacturers now selling weight-loss gray-market peptides to retail buyers online previously supplied fentanyl and amphetamine precursors to transnational drug networks, according to a Chainalysis report published June 4 that looked at the high-volume on-chain peptide ecosystem.
On-chain data identified two suppliers, Shanghai Sigma Audley and Bigreat Technology, as having moved from illicit drug precursor sales into the gray-market peptide trade. The pivot allowed them to sell finished products directly to consumers, capture full retail margins, and reduce their legal exposure compared to operating in the drug precursor supply chain.
Shanghai Sigma Audley generated over $1 million in Bitcoin (BTC) and $3.59 million in stablecoins while operating as a fentanyl precursor supplier. Chainalysis linked those funds to darknet drug vendors and a cartel-connected money laundering operation. As law enforcement pressure on precursor supply chains intensified in 2024, the company began advertising weight-loss and cosmetic peptides on Reddit and body modification forums. It used the same contact number previously linked to its precursor sales listings and shut down its operations in September 2025.
From Fentanyl Precursors to Retail Peptides
Bigreat Technology reportedly supplied precursors for synthetic amphetamines, cathinones, and fentanyl reagents, with blockchain data linking its cryptocurrency addresses to Russian darknet markets. The company created a separate corporate entity, Zhengzhou DEPU Technology, to sell cosmetic and weight-loss peptides to retail buyers. Chainalysis noted that retail customers transacting with these vendors, including buyers fitting the demographic profile of young “looksmaxxing” followers, are likely unaware that the same laboratory supplying their peptides has operated in the illicit drug precursor trade. #Chainalysis #CryptoPayments
The broader gray-market peptide sector has crossed a $100 million annual transaction run rate, with payments processed almost entirely through BTC and stablecoins. Crypto flows into peptide vendor wallets grew from $12 million in Q4 2025 to $32 million in Q1 2026, a 159% increase quarter-over-quarter. The sector is on pace to process roughly $39 million in Q2 2026. Traditional banks and payment processors frequently block transactions involving unregulated or prescription-grade compounds, which pushed the industry toward cryptocurrency as its primary financial infrastructure.
Peptides are short chains of amino acids used in medical and cosmetic treatments, including as the active compounds in weight-loss drugs such as Ozempic and Wegovy. Approved versions are frequently expensive, require prescriptions, and face supply shortages in many markets. Those conditions pushed demand toward overseas suppliers selling unbranded products at significantly lower prices. Chainalysis described cryptocurrency as the backbone that allowed this market to scale.
Safety Testing Drops 88% as Retail Buyers Flood In
The market grew through three distinct phases. The first was a niche underground community of biohackers that averaged roughly $1 million per quarter during most of 2024. The second phase began with increased public attention to alternative health approaches during the period surrounding Robert F. Kennedy Jr.'s nomination to the Department of Health and Human Services. The third phase began in late 2025, when the market intersected with the looksmaxxing subculture on TikTok and related platforms, pushing monthly inflows to $9.9 million and recent peak months above $10 million. #Looksmaxxing
Looksmaxxing is a social media subculture focused on maximizing physical appearance through fitness, grooming, diet, cosmetic procedures, and supplements. Peptide influencers within the subculture have promoted China-based gray-market vendors through paid arrangements and profile links. They have also discouraged followers from accounting for long-term side effects or engaging with regulatory warnings about unverified compounds. Chainalysis noted that the viral pipeline targets a demographic inexperienced with both unregulated pharmaceuticals and cryptocurrency.
Independent safety testing has declined sharply as buyer volumes have grown. Janoshik, a laboratory in Czechia, is widely recognized within gray-market peptide communities as the standard for independent chemical purity testing, having received over $12 million in cryptocurrency for its services since 2023. Per-buyer spending on third-party testing fell by an estimated 88% to just $8 per buyer by the most recent growth phase, even as Janoshik's total monthly inflows grew more than sixfold to roughly $502,000 per month. Vendors commonly post supplier-issued purity certificates online, but experienced buyers have noted that these reports test for mass and purity without addressing sterility. Injecting non-sterile compounds directly into the body carries severe health risks. Chainalysis cited one recent case in which a widely distributed batch of a next-generation weight-loss peptide passed a vendor-supplied purity report but failed an independent sterility test submitted by a cautious consumer. #CryptoGrayMarket
Top-tier vendors receiving average deposits of $1,000 or more have shifted their holdings heavily toward stablecoins, which Chainalysis described as likely a move to shield high-volume supply chain transactions from crypto price volatility. The preference for stablecoins grew more pronounced as vendor scale increased. Smaller operators retain a more varied mix of digital assets.
This article contains links to third-party websites or other content for information purposes only (“Third-Party Sites”). The Third-Party Sites are not under the control of CoinMarketCap, and CoinMarketCap is not responsible for the content of any Third-Party Site, including without limitation any link contained in a Third-Party Site, or any changes or updates to a Third-Party Site. CoinMarketCap is providing these links to you only as a convenience, and the inclusion of any link does not imply endorsement, approval or recommendation by CoinMarketCap of the site or any association with its operators. This article is intended to be used and must be used for informational purposes only. It is important to do your own research and analysis before making any material decisions related to any of the products or services described. This article is not intended as, and shall not be construed as, financial advice. The views and opinions expressed in this article are the author’s [company’s] own and do not necessarily reflect those of CoinMarketCap.
